CRIPTO binding molecules

Details for Australian Patent Application No. 2006203889 (hide)

Owner Biogen Idec MA Inc.

Inventors Glaser, Scott; Wu, Xiufeng; Saldanha, Jose William; Garber, Ellen; Lugovskoy, Alexey Alexandrovich; Van Vlijmen, Herman; Sanicola-Nadel, Michele

Agent Cullen & Co

Pub. Number AU-A-2006203889

PCT Pub. Number WO2006/074397

Priority 60/641,691 05.01.05 US

Filing date 5 January 2006

Wipo publication date 13 July 2006

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/00 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/074397 Priority application(s): WO2006/074397

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203890-Sustained release pharmaceutical formulations comprising ranolazine

2006203884-Cancer prognostic, diagnostic and treatment methods